- Home
- GOVX vs AMST Comparison
GOVX vs AMST Comparison
Compare GOVX & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- AMST
- Stock Information
- Founded
- GOVX 2001
- AMST 2017
- Country
- GOVX United States
- AMST United States
- Employees
- GOVX N/A
- AMST N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- GOVX Health Care
- AMST Technology
- Exchange
- GOVX Nasdaq
- AMST Nasdaq
- Market Cap
- GOVX 16.8M
- AMST 14.0M
- IPO Year
- GOVX N/A
- AMST 2020
- Fundamental
- Price
- GOVX $0.60
- AMST $3.28
- Analyst Decision
- GOVX Strong Buy
- AMST
- Analyst Count
- GOVX 3
- AMST 0
- Target Price
- GOVX $10.67
- AMST N/A
- AVG Volume (30 Days)
- GOVX 1.2M
- AMST 59.8K
- Earning Date
- GOVX 11-11-2025
- AMST 11-13-2025
- Dividend Yield
- GOVX N/A
- AMST N/A
- EPS Growth
- GOVX N/A
- AMST N/A
- EPS
- GOVX N/A
- AMST N/A
- Revenue
- GOVX $6,143,044.00
- AMST $110,459.00
- Revenue This Year
- GOVX N/A
- AMST N/A
- Revenue Next Year
- GOVX N/A
- AMST N/A
- P/E Ratio
- GOVX N/A
- AMST N/A
- Revenue Growth
- GOVX 1943.07
- AMST N/A
- 52 Week Low
- GOVX $0.43
- AMST $2.00
- 52 Week High
- GOVX $3.88
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- GOVX 47.47
- AMST 51.57
- Support Level
- GOVX $0.52
- AMST $3.37
- Resistance Level
- GOVX $0.62
- AMST $3.60
- Average True Range (ATR)
- GOVX 0.05
- AMST 0.19
- MACD
- GOVX 0.01
- AMST 0.00
- Stochastic Oscillator
- GOVX 71.36
- AMST 53.03
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.